We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 19th:
The Clorox Company (CLX - Free Report) : This manufacturer of consumer and professional products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Campbell Soup Company (CPB - Free Report) : This manufacturer of food and beverage products has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Vaxart, Inc. (VXRT - Free Report) : This clinical-stage company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 86.4% over the last 60 days.
Novavax, Inc. (NVAX - Free Report) : This late-stage biotechnology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 24.4% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 19th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 19th:
The Clorox Company (CLX - Free Report) : This manufacturer of consumer and professional products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
The Clorox Company Price and Consensus
The Clorox Company price-consensus-chart | The Clorox Company Quote
Clorox’s shares gained 20.1% over the last one month above the S&P 500’s decrease of 28.9%. The company possesses a Momentum Score of A.
The Clorox Company Price
The Clorox Company price | The Clorox Company Quote
Campbell Soup Company (CPB - Free Report) : This manufacturer of food and beverage products has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Campbell Soup Company Price and Consensus
Campbell Soup Company price-consensus-chart | Campbell Soup Company Quote
Campbell Soup’s shares gained 11.7% over the last one month. The company possesses a Momentum Score of A.
Campbell Soup Company Price
Campbell Soup Company price | Campbell Soup Company Quote
Vaxart, Inc. (VXRT - Free Report) : This clinical-stage company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 86.4% over the last 60 days.
VAXART, INC. Price and Consensus
VAXART, INC. price-consensus-chart | VAXART, INC. Quote
Vaxart’s shares gained 75.5% over the last one month. The company possesses a Momentum Score of B.
VAXART, INC. Price
VAXART, INC. price | VAXART, INC. Quote
Novavax, Inc. (NVAX - Free Report) : This late-stage biotechnology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 24.4% over the last 60 days.
Novavax, Inc. Price and Consensus
Novavax, Inc. price-consensus-chart | Novavax, Inc. Quote
Novavax’s shares gained 18.9% over the last one month. The company possesses a Momentum Score of B.
Novavax, Inc. Price
Novavax, Inc. price | Novavax, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>